Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NASDAQ:EVGN)

4.39
Delayed Data
As of Oct 20
 -0.01 / -0.23%
Today’s Change
4.22
Today|||52-Week Range
6.20
-13.92%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close4.40
Today’s open4.36
Day’s range4.36 - 4.41
Volume4,400
Average volume (3 months)9,737
Market cap$113.0M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-13.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-41.23%
P/E ratio--
Price/Sales19.81
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...+0.08+2.21%
AXSMAxsome Therapeutics ...+0.05+1.01%
--Wang On Group Ltd+0.00+75.00%
PSTIPluristem Therapeuti...-0.04-1.94%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 21, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$6.5M
Annual profit (last year)-$19.6M
Net profit margin-299.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Hamerkaz

Forecasts